NOS2 and malaria: A variety of causes for low bioavailability in malaria have been identified within multiple steps of the NO production pathway [21–23], from low levels of NO synthase (NOS) substrate, arginine [24], to elevated levels of endogenous NOS inhibitors [25,26].